Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non‐sensitized renal transplant patients treated with rapid steroid withdrawal

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0012|29|7|573-580

ISSN： 0902-0063

Source： CLINICAL TRANSPLANTATION (ELECTRONIC), Vol.29, Iss.7, 2015-07, pp. : 573-580

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Steroid withdrawal in renal transplant patients: the Irish experience

By Phelan P.  

Irish Journal of Medical Science, Vol. 180, Iss. 2, 2011-06 ,pp. : 429-433

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of a Weight‐based Rabbit Anti‐thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 8, 2015-08 ,pp. : 748-754

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin‐2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. S183, 2015-05 ,pp. : 23-28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epstein‐Barr virus‐induced polyclonal lymphoproliferative disorder of lymphoplasmacytic type in an autopsy case of aplastic anemia treated twice with anti‐thymocyte globulin therapy

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 5, 2015-05 ,pp. : 274-276

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 3, 2015-03 ,pp. : 222-226

John Wiley & Sons Inc

Access to resources Recommend Favorite